Clarus Therapeutics Shares Are Trading Lower After the Company Announced It Has Received a Non-compliance Letter From Nasdaq. The Shares Will Be Suspended on August 31st and Will Begin Trading on the OTC Pink Market.
Clarus Therapeutics Shares Are Trading Lower After the Company Announced It Has Received a Non-compliance Letter From Nasdaq. The Shares Will Be Suspended on August 31st and Will Begin Trading on the OTC Pink Market.
Clarus Therapeutics宣佈已收到納斯達克的違規信後，股價走低。這些股票將於8月31日停牌，並將開始在場外粉紅市場上交易。
Clarus Therapeutics shares are trading lower after the company announced it has received a non-compliance letter from Nasdaq. The shares will be suspended on August 31st and will begin trading on the OTC Pink Market.
Clarus Therapeutics宣佈已收到納斯達克的違規信後，該公司股價走低。這些股票將於8月31日停牌，並將開始在場外粉紅市場上交易。